Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001493152-23-025154
Filing Date
2023-07-21
Accepted
2023-07-20 21:57:45
Documents
2

Document Format Files

Seq Description Document Type Size
1 formsc13d.htm SC 13D 51556
2 ex99-1.htm EX-99.1 168160
  Complete submission text file 0001493152-23-025154.txt   221031
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Subject) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-46083 | Film No.: 231100999
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address NO. 23 LORONG TERUBONG RIA 2, PAYA TERUBONG GEORGE TOWN N8 11060
Business Address
Choong Choon Hau (Filed by) CIK: 0001986021 (see all company filings)

Type: SC 13D